Podcast


Presenter: Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D

Podcast: BS Medicine Episode #507: Removing the pain from dealing with chronic pain – PART II
0:00

In episode 507, James and Mike and Adrienne continue the discussion about our new clinical practice guideline on pain. We discuss the evidence for the treatments used for back pain and neuropathic pain and give you all the numbers and the nuances.  Show Notes PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #618: From Nerve Pain to Knee Pain: Gabapentinoids for osteoarthritis

In episode 618, Mike K and James chat with Émélie Braschi who helps us go over, yet again, the evidence for the use of gabapentinoids. This time it is for…
Listen 0.5 credits available

BS Medicine Episode #617: A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence

In episode 617, Tina and James bring in Caitlin Finley to review the latest trial that attempts to answer the question of does treating male sexual partners of females undergoing…
Listen 0.5 credits available

BS Medicine Episode #616: Taking the “ouch” out of IUD insertion: Can topical lidocaine help?

In episode 616, Tina and James discuss the issue around the evidence for using topical anesthetics to reduce the pain associated with IUD insertion. To help with this discussion, we…
Listen 0.5 credits available

Presenter(s):

Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Adrienne J Lindblad BSP ACPR PharmD
  • G. Michael Allan MD CCFP
  • James McCormack BSc (Pharm) Pharm D

Spearkers do not have any conflicts of interest to declare.